Phase I improved. Phase II did not.

AI-designed drugs clear safety trials at well above industry rates. At the stage that tests whether a drug works, the sources contradict each other, and the more careful ones report no advantage at all.

添加评论
点赞收藏
点踩分享查看原文
评论
?
参与讨论